Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
2013C042
Product name:
LA COMBINAISON DE PROTEINE DE FUSION NHBA DE NEISSERIA MENINGITIDIS GROUPE B, DE PROTEINE NADA DE NEISSERIA MENINGITIDIS GROUPE B, ET DE PROTEINE DE FUSION FHBP DE NEISSERIA MENINGITIDIS GROUPE B.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic information
Application number:
2013C/042
Type:
Certificate
SPC type:
Medical
Basic patent number:
037584869
Status:
Active
Publication number:
2013C042
1rst applicant's nationality:
Procedural language:
French
Paediatric extension
SPC Extension filing date:
12/01/2026
SPC Extension agent/owner name:
KIRKPATRICK
SPC Extension status:
Open & Published
SPC Extension grant date:
SPC Extension Rejection Date:
Marketing authorization
Marketing authorization number:
EU/1/12/81/001
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
18/01/2013
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)
Dates
Filing date:
27/06/2013
First marketing authorization date:
18/01/2013
Grant date:
07/03/2023
Activation date:
02/10/2023
BE Publication date:
06/06/2018
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
18/01/2028
SPC/SPC Extension Expiration (if granted and all annual fees paid):
18/07/2028
Rejection date:
Withdrawal date:
Applicant
1
Name:
GlaxoSmithKline Biologicals SA
Legal Form:
SA: société anonyme
From:
13/04/2023
Address:
Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)
To:
2
Name:
NOVARTIS VACCINES AND DIAGNOSTICS S.R.L.
Legal Form:
From:
27/06/2013
Address:
-, -, Unknown (UNKNOWN)
To:
12/05/2014
3
Name:
Novartis AG
Legal Form:
From:
12/05/2014
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)
To:
13/04/2023
Agent
1
Name:
KIRKPATRICK
Legal Form:
S.A.
From:
23/12/2020
Address:
Avenue Wolfers 32, 1310, LA HULPE, Brabant wallon, Belgium (BE)
To:
2
Name:
PLUCKER Guy
Legal Form:
From:
27/06/2013
Address:
Avenue Wolfers 32, 1310, LA HULPE, Belgium (BE)
To:
23/12/2020
Publication
Bulletin
1
Bulletin heading:
SPC
Journal edition number:
2018/14
Publication date:
22/08/2018
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates
2
Bulletin heading:
SPC
Journal edition number:
2023/05
Publication date:
29/03/2023
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates
3
Bulletin heading:
CO
Journal edition number:
2023/09
Publication date:
25/05/2023
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders
4
Bulletin heading:
SPC
Journal edition number:
2023/19
Publication date:
19/10/2023
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates
5
Bulletin heading:
SPC
Journal edition number:
2026/03
Publication date:
26/02/2026
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates
Deed
Change of owner(s)
Change Kind / Decision Type:
Assignment
Deed number:
RC2023100359A
Registration date:
13/04/2023
License effective date:
License expiration date:
Scope of license:
Deed filer:
KIRKPATRICK
Bulletin edition number:
Text:
Country code:
Updated license number:
Terminated license number:
Removed pledgee
Name:
Address:
Changed pledgee
Name:
Address:
Removed usufructuary
Name:
Address:
Added usufructuary
Name:
Address:
Changed usufructuary
Name:
Address:
Annual fee
Annual fee(s) Due Date:
03/11/2026
Annual fee number:
24
Annual fee amount:
800 Euro
Expected payer:
Last annual fee payment date:
23/09/2025
Last annual fee paid number:
23
Last annual fee paid amount:
750 Euro
Payer:
ANAQUA SERVICES
Filing date
Document type
Publication Type
Document Description
Number of pages
File Type
06/06/2018
Publication
I1
1
PDF
/2/4/0/3/1/0300013042/docs/2013c042_0_i1document_20180606_142846847.pdf
23/03/2023
Request For Change
Letter and/or Form requesting a change in the Register
1
PDF
/2/4/0/3/1/0300013042/docs/2013c042_1_rfc_20230404_080933441.pdf
09/08/2022
General Document
Other
2
PDF
/2/4/0/3/1/0300013042/docs/2013c042_2_generaldocument_20220809_100417782.pdf
13/04/2023
Request For Change
Letter and/or Form requesting a change in the Register
3
PDF
/2/4/0/3/1/0300013042/docs/2013c042_3_rfc_20230414_084547575.pdf
13/04/2023
Request For Change
Deed or extract stating the change of the rights
4
PDF
/2/4/0/3/1/0300013042/docs/2013c042_4_rfc_20230414_084547982.pdf
13/04/2023
Request For Change
Free translation of the deed or extract
2
PDF
/2/4/0/3/1/0300013042/docs/2013c042_5_rfc_20230414_084547705.pdf
13/04/2023
Incoming Correspondence (Email)
Cover letter
1
PDF
/2/4/0/3/1/0300013042/docs/2013c042_6_incomingcorrespondenceelectronic_20230414_084548182.pdf
13/04/2023
Outgoing Correspondence
1
PDF
/2/4/0/3/1/0300013042/docs/2013c042_7_outgoingcorrespondence_20230414_084547451.pdf
07/03/2023
Publication
I2
1
PDF
/2/4/0/3/1/0300013042/docs/2013c042_8_i2document_20230307_080256244.pdf
07/03/2023
Certificate
2
PDF
/2/4/0/3/1/0300013042/docs/2013c042_9_spc_medcertificate_20230307_080256571.pdf
07/03/2023
Outgoing Correspondence
2
PDF
/2/4/0/3/1/0300013042/docs/2013c042_10_outgoingcorrespondence_20230315_103056012.pdf
06/10/2022
Incoming Correspondence (Email)
Cover letter
2
PDF
/2/4/0/3/1/0300013042/docs/2013c042_11_incomingcorrespondenceelectronic_20221007_084521412.pdf
12/01/2026
General Document
Other
4
PDF
/2/4/0/3/1/0300013042/docs/2013c042_12_generaldocument_20260113_084540756.pdf
12/01/2026
General Document
Other
38
PDF
/2/4/0/3/1/0300013042/docs/2013c042_13_generaldocument_20260113_084540945.pdf
12/01/2026
General Document
Other
2
PDF
/2/4/0/3/1/0300013042/docs/2013c042_14_generaldocument_20260113_084542216.pdf
12/01/2026
General Document
Other
2
PDF
/2/4/0/3/1/0300013042/docs/2013c042_15_generaldocument_20260113_084540682.pdf
12/01/2026
Marketing Authorization
1st Paediatric Marketing Authorization (EU)
3
PDF
/2/4/0/3/1/0300013042/docs/2013c042_16_marketingauthorization_20260113_084542404.pdf
12/01/2026
Application Form
5
PDF
/2/4/0/3/1/0300013042/docs/2013c042_17_applicationform_20260113_084542701.pdf
12/01/2026
Paediatric Investigation Plan
Paediatric Investigation Plan (PIP)
12
PDF
/2/4/0/3/1/0300013042/docs/2013c042_18_paediatricinvestigationplan_20260113_084542595.pdf
03/02/2026
Publication
I1E
1
PDF
/2/4/0/3/1/0300013042/docs/2013c042_19_i1edocument_20260203_163158272.pdf